Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Wee

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2009
Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cellsSaskia M Brachmann, Irmgard Hofmann, Christian Schnell, et al.
Cancer Research|April 30, 2009
PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancersSusan Wee, Zainab Jagani, Kay Xiaoqin Xiang, et al.
Annals of the New York Academy of Sciences|February 28, 2014
Targeting epigenetic regulators for cancer therapySusan Wee, Dash Dhanak, Haitao Li, et al.
Cancer Research|August 25, 2018
Inhibition of Casein Kinase 2 Disrupts Differentiation of Myeloid Cells in Cancer and Enhances the Efficacy of Immunotherapy in MiceAyumi Hashimoto, Chan Gao, Jerome Mastio, et al.
Veterinary Pathology|January 18, 2018
Systemic Loss of C-terminal Src Kinase Expression Elicits Spontaneous Suppurative Inflammation in Conditional Knockout MiceLisa D Berman-Booty, Rukiye Eraslan, Umesh Hanumegowda, et al.
Cell Cycle (Georgetown, Tex.)|January 30, 2009
Single-vector inducible lentiviral RNAi system for oncology target validationDmitri Wiederschain, Susan Wee, Lin Chen, et al.
Oncoimmunology|August 5, 2021
DGKζ exerts greater control than DGKα over CD8<sup>+</sup> T cell activity and tumor inhibitionJunchen Gu, Cindy Wang, Carolyn Cao, et al.
Molecular Cancer Therapeutics|August 9, 2015
Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene ExpressionRyan Lenhart, Stefan Kirov, Heshani Desilva, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
Discovery of Potent, Dual-Inhibitors of Diacylglycerol Kinases Alpha and Zeta Guided by Phenotypic OptimizationLouis Chupak, Michael Wichroski, Xiaofan Zheng, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Discovery of Pyridazinone and Pyrazolo[1,5-<i>a</i>]pyridine Inhibitors of C-Terminal Src KinaseDaniel P O'Malley, Vijay Ahuja, Brian Fink, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2009
Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cellsSaskia M Brachmann, Irmgard Hofmann, Christian Schnell, et al.
Cancer Research|April 30, 2009
PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancersSusan Wee, Zainab Jagani, Kay Xiaoqin Xiang, et al.
Annals of the New York Academy of Sciences|February 28, 2014
Targeting epigenetic regulators for cancer therapySusan Wee, Dash Dhanak, Haitao Li, et al.
Cancer Research|August 25, 2018
Inhibition of Casein Kinase 2 Disrupts Differentiation of Myeloid Cells in Cancer and Enhances the Efficacy of Immunotherapy in MiceAyumi Hashimoto, Chan Gao, Jerome Mastio, et al.
Veterinary Pathology|January 18, 2018
Systemic Loss of C-terminal Src Kinase Expression Elicits Spontaneous Suppurative Inflammation in Conditional Knockout MiceLisa D Berman-Booty, Rukiye Eraslan, Umesh Hanumegowda, et al.
Cell Cycle (Georgetown, Tex.)|January 30, 2009
Single-vector inducible lentiviral RNAi system for oncology target validationDmitri Wiederschain, Susan Wee, Lin Chen, et al.
Oncoimmunology|August 5, 2021
DGKζ exerts greater control than DGKα over CD8<sup>+</sup> T cell activity and tumor inhibitionJunchen Gu, Cindy Wang, Carolyn Cao, et al.
Molecular Cancer Therapeutics|August 9, 2015
Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene ExpressionRyan Lenhart, Stefan Kirov, Heshani Desilva, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
Discovery of Potent, Dual-Inhibitors of Diacylglycerol Kinases Alpha and Zeta Guided by Phenotypic OptimizationLouis Chupak, Michael Wichroski, Xiaofan Zheng, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Discovery of Pyridazinone and Pyrazolo[1,5-<i>a</i>]pyridine Inhibitors of C-Terminal Src KinaseDaniel P O'Malley, Vijay Ahuja, Brian Fink, et al.
Pageof 3